Neuroprotective Agent Improved Outcomes After Acute Ischemic Stroke

By News Health
2 weeks Ago

(MedPage Today) — NEW ORLEANS — Loberamisal improved functional outcomes after acute ischemic stroke in a placebo-controlled phase III trial, raising its prospects as an investigational neuroprotective therapy.
In patients with relatively…

Source link : https://www.medpagetoday.com/meetingcoverage/isc/119779

Author :

Publish date : 2026-02-06 20:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Predictors of Anti-TNF Nonresponse in IBD Found

Going Home: Discharge Tips for CMC Patients

Federal Health Data is Back Online, But Docs Still Skeptical

FDA Proposes New Approval Pathway for Rare Disease Gene Therapy

RFK Jr. May Eliminate the USPSTF, Original Task Force Members Warn

Small Study Warns on Microplastics and Prostate Tumors